Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
In clinical trials of Tirzepatide, a dual-acting GLP-1 and GIP agonist currently prescribed for Type 2 diabetes, obese patients lost 21 percent body mass in 1.4 years, surpassing the 15 percent reduction seen with Semaglutide
The medicine works by copying a hormone in the body called GLP-1 (glucagon-like peptide-1)
Weight loss is only one part of the decision
You can always ask your provider to check your B12 levels
US$ 24.74
US$ 21.50
US$ 21.49
US$ 20.11
US$ 27.87
US$ 25.44
US$ 25.88
US$ 20.96
US$ 24.79
US$ 26.50
US$ 25.76
